Genomic and Precision Medicine: Oncology
Genomic and Precision Medicine: Oncology
YOU SAVE £8.52
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
- More about Genomic and Precision Medicine: Oncology
The book "Genomic and Precision Medicine: Oncology, Third Edition" focuses on the applications of genome discovery for personalized cancer therapies, covering risk assessment, diagnosis, prognosis, pharmacogenomics, and emerging opportunities.
Format: Hardback
Length: 378 pages
Publication date: 14 April 2022
Publisher: Elsevier Science Publishing Co Inc
Genomic and Precision Medicine: Oncology, Third Edition delves into the realm of genome discovery, paving the way for personalized cancer therapies. This comprehensive text is meticulously organized to explore the diverse applications of genomics and personalized medicine tools and technologies in risk assessment and susceptibility, diagnosis and prognosis, pharmacogenomics and precision therapeutics, and emerging and future opportunities within the field.
In the opening chapter, the authors provide a comprehensive overview of the significance of genomics in oncology. They highlight the vast potential of genome sequencing and analysis to unravel the complex genetic underpinnings of cancer and identify personalized treatment strategies. The chapter underscores the importance of integrating genomics with other omics disciplines, such as proteomics and metabolomics, to obtain a holistic understanding of cancer biology and develop more effective therapies.
The subsequent chapters delve into the application of genomics and personalized medicine tools and technologies in risk assessment and susceptibility. The authors discuss the use of genetic testing and biomarker analysis to identify individuals who are at high risk of developing certain cancers and to guide personalized prevention and screening strategies. They also explore the role of genomics in predicting the response to chemotherapy and radiation therapy and developing targeted therapies based on genetic mutations.
Diagnosis and prognosis are two critical aspects of cancer care that are heavily influenced by genomics. The authors discuss the use of genomic sequencing and other advanced technologies to accurately diagnose cancer and predict its progression. They explore the role of genetic testing in identifying genetic mutations that contribute to cancer development and prognosis and the development of personalized treatment plans based on these findings.
Pharmacogenomics and precision therapeutics are emerging fields that hold great promise for personalized cancer treatment. The authors discuss the use of genetic information to guide drug selection and dosing, ensuring optimal therapeutic outcomes and minimizing side effects. They explore the development of personalized medicine vaccines and therapeutics tailored to individual patient characteristics.
The final chapter focuses on emerging and future opportunities in the field of genomic and precision medicine in oncology. The authors discuss the use of artificial intelligence and machine learning to analyze large datasets and identify new biomarkers and therapeutic targets. They also explore the role of precision medicine in addressing the unique genetic and molecular characteristics of different cancer subtypes and developing personalized treatment strategies.
In conclusion, Genomic and Precision Medicine: Oncology, Third Edition is a comprehensive and authoritative text that provides a deep understanding of the applications of genome discovery in personalized cancer therapy. By integrating genomics with other omics disciplines and leveraging advanced technologies, this text empowers healthcare professionals to deliver precision medicine to cancer patients, improving outcomes and quality of life.
Genomic and Precision Medicine: Oncology, Third Edition delves into the realm of genome discovery, paving the way for personalized cancer therapies. This comprehensive text is meticulously organized to explore the diverse applications of genomics and personalized medicine tools and technologies in risk assessment and susceptibility, diagnosis and prognosis, pharmacogenomics and precision therapeutics, and emerging and future opportunities within the field.
In the opening chapter, the authors provide a comprehensive overview of the significance of genomics in oncology. They highlight the vast potential of genome sequencing and analysis to unravel the complex genetic underpinnings of cancer and identify personalized treatment strategies. The chapter underscores the importance of integrating genomics with other omics disciplines, such as proteomics and metabolomics, to obtain a holistic understanding of cancer biology and develop more effective therapies.
The subsequent chapters delve into the application of genomics and personalized medicine tools and technologies in risk assessment and susceptibility. The authors discuss the use of genetic testing and biomarker analysis to identify individuals who are at high risk of developing certain cancers and to guide personalized prevention and screening strategies. They also explore the role of genomics in predicting the response to chemotherapy and radiation therapy and developing targeted therapies based on genetic mutations.
Diagnosis and prognosis are two critical aspects of cancer care that are heavily influenced by genomics. The authors discuss the use of genomic sequencing and other advanced technologies to accurately diagnose cancer and predict its progression. They explore the role of genetic testing in identifying genetic mutations that contribute to cancer development and prognosis and the development of personalized treatment plans based on these findings.
Pharmacogenomics and precision therapeutics are emerging fields that hold great promise for personalized cancer treatment. The authors discuss the use of genetic information to guide drug selection and dosing, ensuring optimal therapeutic outcomes and minimizing side effects. They explore the development of personalized medicine vaccines and therapeutics tailored to individual patient characteristics.
The final chapter focuses on emerging and future opportunities in the field of genomic and precision medicine in oncology. The authors discuss the use of artificial intelligence and machine learning to analyze large datasets and identify new biomarkers and therapeutic targets. They also explore the role of precision medicine in addressing the unique genetic and molecular characteristics of different cancer subtypes and developing personalized treatment strategies.
In conclusion, Genomic and Precision Medicine: Oncology, Third Edition is a comprehensive and authoritative text that provides a deep understanding of the applications of genome discovery in personalized cancer therapy. By integrating genomics with other omics disciplines and leveraging advanced technologies, this text empowers healthcare professionals to deliver precision medicine to cancer patients, improving outcomes and quality of life.
Weight: 718g
Dimension: 169 x 238 x 24 (mm)
ISBN-13: 9780128006849
Edition number: 3 ed
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.